Laffleur Brice, Pascal Virginie, Sirac Christophe, Cogné Michel
CNRS UMR6101, Contrôle des Réponses Immunes B et Lymphoproliférations, Université de Limoges, Limoges, France.
Methods Mol Biol. 2012;901:149-59. doi: 10.1007/978-1-61779-931-0_9.
Mice are widely available laboratory animals that can easily be used for the production of antibodies against a broad range of antigens, using well-defined immunization protocols. Such an approach allows optimal in vivo affinity maturation of the humoral response. In addition, high-affinity antibodies arising in this context can readily be further characterized and produced as monoclonals after immortalizing and selecting specific antibody-producing cells through hybridoma derivation. Using such conventional strategies combined with mice that are either genetically engineered to carry humanized immunoglobulin (Ig) genes or engrafted with a human immune system, it is thus easy to obtain and immortalize clones that produce either fully human Ig or antibodies associating variable (V) domains with selected antigen specificities to customized human-like constant regions, with defined effector functions. In some instances, where there is a need for in vivo functional assays of a single antibody with a known specificity, it might be of interest to transiently express that gene in mice by in vivo gene transfer. This approach allows a rapid functional assay. More commonly, mice are used to obtain a diversified repertoire of antibody specificities after immunization by producing antibody molecules in the mouse B cell lineage from mouse strains with transgene Ig genes which are of human, humanized, or chimeric origin. After in vivo maturation of the immune response, this will lead to the secretion of antibodies with optimized antigen binding sites, associated to the desired human constant domains. This chapter focuses on two simple methods: (1) to obtain such humanized Ig mice and (2) to transiently express a human Ig gene in mice using hydrodynamics-based transfection.
小鼠是广泛可得的实验动物,利用明确的免疫方案,它们可轻松用于制备针对多种抗原的抗体。这种方法能使体液免疫反应在体内实现最佳的亲和力成熟。此外,在此过程中产生的高亲和力抗体,在通过杂交瘤衍生使特定抗体产生细胞永生化并进行筛选后,可很容易地进一步鉴定并制备成单克隆抗体。将这些传统策略与经过基因工程改造以携带人源化免疫球蛋白(Ig)基因或移植了人类免疫系统的小鼠相结合,就很容易获得并使产生完全人源Ig或具有将可变(V)结构域与选定抗原特异性关联到定制的类人恒定区且具有明确效应功能的抗体的克隆永生化。在某些情况下,若需要对具有已知特异性的单一抗体进行体内功能测定,通过体内基因转移在小鼠中瞬时表达该基因可能会很有意义。这种方法能实现快速的功能测定。更常见的是,通过在具有人源、人源化或嵌合来源的转基因Ig基因的小鼠品系的B细胞谱系中产生抗体分子,小鼠在免疫后可获得多样化的抗体特异性库。免疫反应在体内成熟后,这将导致分泌具有优化抗原结合位点且与所需人恒定结构域相关的抗体。本章重点介绍两种简单方法:(1)获得此类人源化Ig小鼠,(2)利用基于流体动力学的转染在小鼠中瞬时表达人Ig基因。